Management of Ionized Calcium in Cardiac Disease
Monitoring and Treatment
- In patients with cardiac disease, ionized calcium (iCa) should be monitored selectively rather than routinely, with treatment reserved for symptomatic hypocalcemia or levels below 0.8-0.9 mmol/L, using calcium chloride (20 mg/kg IV) as the preferred agent due to its superior elemental calcium delivery compared to calcium gluconate, as recommended by the American College of Cardiology 1
- Selective monitoring is appropriate in specific high-risk scenarios, such as massive transfusion protocols, where citrate-induced hypocalcemia requires close monitoring 1
- Calcium channel blocker toxicity requires iCa monitoring to guide treatment decisions, according to the American Heart Association 2, 3
Normal Range and Clinical Significance
- The normal iCa range is 1.1-1.3 mmol/L (or 1.15-1.36 mmol/L), and iCa represents 45-50% of total calcium, as stated by the National Institutes of Health 4, 1
- pH affects iCa levels, with each 0.1 unit increase in pH decreasing iCa by approximately 0.05 mmol/L, according to the American College of Cardiology 4, 1
Treatment Thresholds
- Calcium chloride is preferred over calcium gluconate for treating hypocalcemia, providing three times more elemental calcium, as recommended by the American College of Cardiology 1
- Adult dosing for calcium chloride is 2000 mg (20 mL of 10% solution) IV, while pediatric dosing is 20 mg/kg IV, according to the American Academy of Pediatrics 1, 3
Critical Drug Interactions in Cardiac Patients
- For calcium channel blocker toxicity, infuse 20 mg/kg (0.2 mL/kg) of 10% calcium chloride over 5-10 minutes, and monitor serum iCa to prevent hypercalcemia, as recommended by the American Heart Association 2
Special Cardiac Scenarios
- High-dose epinephrine infusion may be effective for beta-blocker toxicity, and consider glucagon (5-10 mg over several minutes, then 1-5 mg/hour infusion in adolescents), according to the American Heart Association 2